FI963036A0 - Munasarjan estrogeenista riippuvaisten tilojen hoito - Google Patents

Munasarjan estrogeenista riippuvaisten tilojen hoito

Info

Publication number
FI963036A0
FI963036A0 FI963036A FI963036A FI963036A0 FI 963036 A0 FI963036 A0 FI 963036A0 FI 963036 A FI963036 A FI 963036A FI 963036 A FI963036 A FI 963036A FI 963036 A0 FI963036 A0 FI 963036A0
Authority
FI
Finland
Prior art keywords
treatment
estrogen
ovary
administration
dependent conditions
Prior art date
Application number
FI963036A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963036A (fi
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of FI963036A publication Critical patent/FI963036A/fi
Publication of FI963036A0 publication Critical patent/FI963036A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI963036A 1994-02-04 1996-08-01 Munasarjan estrogeenista riippuvaisten tilojen hoito FI963036A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions
PCT/US1995/001479 WO1995020972A1 (en) 1994-02-04 1995-02-02 Treatment of ovarian estrogen dependent conditions

Publications (2)

Publication Number Publication Date
FI963036A FI963036A (fi) 1996-08-01
FI963036A0 true FI963036A0 (fi) 1996-08-01

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963036A FI963036A0 (fi) 1994-02-04 1996-08-01 Munasarjan estrogeenista riippuvaisten tilojen hoito

Country Status (29)

Country Link
US (1) US5681817A (bg)
EP (1) EP0785792B1 (bg)
JP (1) JP3130048B2 (bg)
KR (1) KR970700507A (bg)
CN (1) CN1144486A (bg)
AP (1) AP724A (bg)
AT (1) ATE179610T1 (bg)
AU (1) AU689229B2 (bg)
BG (1) BG62238B1 (bg)
BR (1) BR9506606A (bg)
CA (1) CA2182183C (bg)
CZ (1) CZ291709B6 (bg)
DE (1) DE69509544T2 (bg)
DK (1) DK0785792T3 (bg)
ES (1) ES2132645T3 (bg)
FI (1) FI963036A0 (bg)
GR (1) GR3030164T3 (bg)
HU (1) HUT74622A (bg)
LT (1) LT4182B (bg)
LV (1) LV11782B (bg)
MD (1) MD1432C2 (bg)
NZ (1) NZ281441A (bg)
OA (1) OA10777A (bg)
PL (1) PL178273B1 (bg)
RO (1) RO117420B1 (bg)
RU (1) RU2110274C1 (bg)
SK (1) SK96296A3 (bg)
TJ (1) TJ242B (bg)
WO (1) WO1995020972A1 (bg)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114655A (en) * 1994-07-22 2005-08-31 Hampton Roads Medical College USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2306110A1 (en) 1997-10-17 1999-04-29 Mochida Pharmaceutical Co., Ltd. Therapeutic agent of uterine leiomyoma, containing dienogest as effective ingredient
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6417214B1 (en) * 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
KR100864547B1 (ko) * 1999-08-31 2008-10-20 바이엘 쉐링 파마 악티엔게젤샤프트 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP2004512369A (ja) * 2000-10-30 2004-04-22 ユニバーシティ・オブ・チューリッヒ 尿失禁の治療のためのｇｎｒｈアナログ
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
ES2366654T3 (es) * 2005-02-17 2011-10-24 HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. Biofosfonatos para tratar la endometriosis.
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
SI3263112T1 (sl) * 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
US20080287408A1 (en) * 2007-05-14 2008-11-20 Drugtech Corporation Endometriosis treatment
AU2008300199B2 (en) * 2007-09-20 2013-09-12 Lapidot Medical Import And Marketing Ltd Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
KR101585221B1 (ko) 2014-02-27 2016-01-13 권희완 지압대 겸용 지압 베개
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ES2102397T3 (es) 1990-03-16 1997-08-01 Applied Research Systems Tratamiento de la enfermedad del ovario policistico.
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
PL315792A1 (en) 1996-12-09
BG100766A (bg) 1997-06-30
LV11782A (lv) 1997-06-20
CA2182183C (en) 2003-09-16
MD1432B2 (en) 2000-03-31
BG62238B1 (bg) 1999-06-30
CA2182183A1 (en) 1995-08-10
KR970700507A (ko) 1997-02-12
WO1995020972A1 (en) 1995-08-10
EP0785792A1 (en) 1997-07-30
MD1432C2 (ro) 2000-09-30
HU9601969D0 (en) 1996-09-30
AU1838695A (en) 1995-08-21
NZ281441A (en) 1999-09-29
HUT74622A (en) 1997-01-28
LV11782B (en) 1997-12-20
JP3130048B2 (ja) 2001-01-31
DE69509544T2 (de) 1999-09-02
RO117420B1 (ro) 2002-03-29
SK96296A3 (en) 1997-07-09
JPH09508418A (ja) 1997-08-26
EP0785792A4 (bg) 1997-07-30
CN1144486A (zh) 1997-03-05
AP9600840A0 (en) 1996-07-31
DE69509544D1 (de) 1999-06-10
US5681817A (en) 1997-10-28
TJ242B (en) 1999-11-24
LT4182B (en) 1997-06-25
CZ291709B6 (cs) 2003-05-14
GR3030164T3 (en) 1999-08-31
EP0785792B1 (en) 1999-05-06
FI963036A (fi) 1996-08-01
RU2110274C1 (ru) 1998-05-10
AU689229B2 (en) 1998-03-26
ATE179610T1 (de) 1999-05-15
CZ210396A3 (en) 1997-05-14
DK0785792T3 (da) 1999-10-18
BR9506606A (pt) 1997-09-09
PL178273B1 (pl) 2000-03-31
ES2132645T3 (es) 1999-08-16
OA10777A (en) 2002-12-23
AP724A (en) 1999-01-18
LT96133A (en) 1997-01-27

Similar Documents

Publication Publication Date Title
FI963036A (fi) Munasarjan estrogeenista riippuvaisten tilojen hoito
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
FI941262A0 (fi) 3-aroyylibentso(b)tiofeenien sulfonaatti- ja karbamaattijohdannaisia
PH30747A (en) Combination therapy for the treatment of estrogen sensitive disease.
ATE183198T1 (de) Immunogens gegen gonadotropin releasing hormone
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
NO20005145L (no) FremgangsmÕte for behandling av fertilitetsproblemer
DE69831241D1 (de) Gonadotropin releasing hormon antagonist
WO2002072106A3 (en) Combined method for treating hormono-dependent disorders with exemestane
NO985573L (no) Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose
CA2195745A1 (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
JO1879B1 (en) Consolidation of the secretion of ovarian estrogen for prolonged treatment regimens
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
BR9406666A (pt) Método e kit de prevencão ou inibição de fecundação
UA29349A (uk) Спосіб лікування ановуляторної неплідності

Legal Events

Date Code Title Description
MA Patent expired